NRX Pharmaceuticals Inc (NRXP) is a biotechnology company listed on US.
Latest reported NRXP revenue for 2025-12-31 was $1.2M. Net income was -$28.6M. NRXP currently screens at market cap $169.9M.
Use this NRXP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NRXP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NRXP SEC filings page. Lician reads the product cache first so this HTML stays unique to NRX Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NRXP income, balance, and cash tables.